Novel MRI technique shows lasting effects in treatment of severe depression
Bharti Jayshankar January 26, 2024: A recent UK-based BRIGhTMIND trial sheds light on the comparable effectiveness and safety of two advanced neuromodulation MRI.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Bharti Jayshankar January 26, 2024: A recent UK-based BRIGhTMIND trial sheds light on the comparable effectiveness and safety of two advanced neuromodulation MRI.
Bharti Jayshankar January 26, 2024: A recent study has uncovered an unexpected benefit of medications commonly prescribed for obesity and type 2 diabetes:.
Bharti Jayshankar January 25, 2024: A new gene therapy has demonstrated remarkable success in treating inherited deafness. Two separate studies, one conducted by.
Bharti Jayshankar January 25, 2024: Scientists at the University of Alabama-Birmingham’s Marnix E. Heersink School of Medicine have successfully transplanted genetically modified pig.
Bharti Jayshankar January 24, 2024: A new comprehensive study says the extent of bird extinctions since the Late Pleistocene has been vastly underestimated,.
Bharti Jayshankar January 24, 2024: Researchers in the UK and Switzerland have successfully grown miniature placentas in a laboratory setting, offering new insights.
HQ Team January 20, 2024: Measles is fast witnessing a surge across the world and the latest region reporting an upsurge is central.
HQ Team January 19, 2024: GSK is giving up more of its stake in Haleon, the consumer health business the British pharma giant.
HQ Team January 19, 2024: A comprehensive multicohort genome-wide association study (GWAS), led by researchers at the Perelman School of Medicine at the.
HQ Team January 18, 2024: The FDA has approved US-based DermaSensor Inc.’s handheld wireless skin cancer detection device that is powered by artificial.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com